Skip to main content

Table 2 Classification of ARDS patients with one or more respiratory tract sample positive for Aspergillus spp., according to the Blot algorithm, adapted from Blot et al. [16]

From: Aspergillus-positive lower respiratory tract samples in patients with the acute respiratory distress syndrome: a 10-year retrospective study

 

Immunosuppression

(n = 17)a

No Immunosuppression

(n = 18)

Proven invasive pulmonary aspergillosis (n = 1)

1 (6)

0 (0)

Putative invasive pulmonary aspergillosis (n = 16)

11 (65)

5 (28)b

1. Aspergillus-positive lower respiratory tract specimen culture

17

18

2. Compatible signs and symptoms

  

Fever refractory to at least 3 d of appropriate antibiotic therapy

3

1

Recrudescent fever after a period of defervescence of at least 48 h while still on antibiotics and without other apparent cause

1

0

Pleuritic chest pain

1

0

Pleuritic rub

0

0

Dyspnea

0

0

Hemoptysis

1

0

Worsening respiratory insufficiency in spite of appropriate antibiotic therapy and ventilatory support

6

11

3. Abnormal medical imaging by portable chest X-ray or CT scan of the lungs

17

18

4a. Host risk factors

17

0

Neutropenia (absolute neutrophil count < 0.5 G/L) preceding or at the time of ICU admission

4

0

Underlying hematological or oncological malignancy treated with cytotoxic agents

5

0

Glucocorticoid treatment (prednisone equivalent >20 mg/d and >4 weeks)

1

0

Congenital or acquired immunodeficiency

7

0

4b. Semiquantitative Aspergillus-positive culture of BAL fluid (+ or ++), without bacterial growth together with a positive cytological smear showing branching hyphae

4

6

Aspergillus respiratory tract colonization (n = 18)

5 (29)

13 (72)c

  1. aHematological malignancies (n = 7, including lymphoma (n = 5), acute leukemia (n = 2), one of whom required allogeneic bone marrow transplant), solid organ transplant (n = 6), gastric cancer (n = 1), HIV infection (n = 1), neutropenia of unknown cause (n = 1) and connective tissue disease under corticosteroid treatment (n = 1)
  2. b p = 0.018 and c p = 0.015 (Fisher’s exact test) for comparison between immunosuppressed and non-immunosuppressed patients; continuous variables are shown as median (interquartile range 25–75); categorical variables are shown as n (%)